Meme kanserinde kemoterapi semptom yönetimi-öz etkililik ölçeğinin geçerlik ve güvenirliği

Basit Öğe Kaydı
dc.contributor.advisorSağlam, Rabia
dc.contributor.authorSemiz, Demet
dc.date.accessioned2024-07-12T22:14:29Z
dc.date.available2024-07-12T22:14:29Z
dc.date.issued2018-09en_US
dc.date.submitted2018-09en_US
dc.departmentEnstitüler, Lisansüstü Eğitim Enstitüsü, Cerrahi Hastalıkları Hemşireliği Ana Bilim Dalıen_US
dc.description.abstractThis methodological study aimed at evaluating the validity and reliability of the Symptom-Management Self-Efficacy Scale Related to Chemotherapy in Breast Cancer. The study was conducted at the chemotherapy unit of a public hospital located in Istanbul between November 2017 and September 2018. No sampling method was used for the study and 248 female subjects who met the inclusion criteria and agreed to participate in the study were included. The study data were collected by way of face-to-face interviews using a Patient Description Form and the Symptom-Management Self-Efficacy Scale Related to Chemotherapy in Breast Cancer. Language, content and construct validity and reliability analyses were used to assess the validity and reliability of the scale. The language validity of the Symptom-Management Self-Efficacy Scale Related to Chemotherapy in Breast Cancer was analyzed using the translation and back-translation method and its content validity was verified through expert views. The scale was presented to 12 experts for their views on its content validity. After assessing the content validity using the Davis technique together with expert views, the CVI value of the items of the Symptom-Management Self-Efficacy Scale Related to Chemotherapy in Breast Cancer was found to be 0.912. Scale factor value changed between 0.30-0.80. Just as the original version it was evaluated as three lower dimensional by factor analysis . As a result of the internal consistency analysis of the scale, the total item score correlations were found to be sufficient and its Cronbach alpha coefficient to be 0.905. In conclusion, the Symptom-Management Self-Efficacy Scale Related to Chemotherapy in Breast Cancer was found to be a valid and reliable measurement tool in Turkish language.en_US
dc.identifier.citationSemiz, Demet (2018). Meme kanserinde kemoterapi semptom yönetimi-öz etkililik ölçeğinin geçerlik ve güvenirliği (Yayınlanmamış Yüksek Lisans Tezi). Maltepe Üniversitesi, Sağlık Bilimleri Enstitüsü, İstanbul.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/10027
dc.institutionauthorSemiz, Demeten_US
dc.language.isotren_US
dc.publisherMaltepe Üniversitesi, Sağlık Bilimleri Enstitüsüen_US
dc.relation.publicationcategoryTezen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKT0161en_US
dc.subjectMeme kanserien_US
dc.subjectKemoterapien_US
dc.subjectHemşireliken_US
dc.subjectSemptom yönetimien_US
dc.subjectÖz etkililiken_US
dc.subjectGeçerliken_US
dc.subjectGüvenirliken_US
dc.subjectBreast canceren_US
dc.subjectChemotherapyen_US
dc.subjectNursingen_US
dc.subjectSymptom managementen_US
dc.subjectSelf-efficacyen_US
dc.subjectValidityen_US
dc.subjectReliabilityen_US
dc.titleMeme kanserinde kemoterapi semptom yönetimi-öz etkililik ölçeğinin geçerlik ve güvenirliğien_US
dc.title.alternativeValidity and reliability of the symptom-management self-efficacy scale related to chemotherapy in breast canceren_US
dc.typeMaster Thesisen_US
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Demet_Semiz_Meme_Kanserinde_Kemoterapi.pdf
Boyut:
1.98 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full text
İndir

Koleksiyon

Lisansüstü Eğitim Enstitüsü Tez Koleksiyonu